Iron exposure modifies acetylcholinesterase activity in zebrafish (Danio rerio) tissues: Distinct susceptibility of tissues to iron overload

Fish Physiology and Biochemistry

Volumn 37, Issue 3, 2011, Pages 573-581

  Sant'Anna, M C B ^a   de Soares, Vanessa Matas ^a   Seibt, Kelly Juliana ^a   Ghisleni, Gabriele ^a   Rico, Eduardo Pacheco ^b   Rosemberg, Denis Broock ^b   de Oliveira, Jarbas Rodrigues ^a   Schröder, Nadja ^a,c   Bonan, Carla Denise ^a,c   Bogo, Mauricio Reis ^a,c  

^a PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^c Instituto Nacional Translacional em Medicina (INCT TM)   (Brazil)

Author keywords

Acetylcholinesterase activity; Iron toxicity; Zebrafish

Indexed keywords

ACETYLCHOLINESTERASE; IRON;

ANIMAL; ARTICLE; BRAIN; DOSE RESPONSE; DRUG EFFECT; ENZYMOLOGY; FEMALE; GENE EXPRESSION REGULATION; LIVER; MALE; METABOLISM; ZEBRA FISH;

ACETYLCHOLINESTERASE; ANIMALS; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; IRON; LIVER; MALE; ZEBRAFISH;

DANIO RERIO;

EID: 79960977219     PISSN: 09201742     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10695-010-9459-7     Document Type: Article

References (49)

1. Anghelescu I, Heuser I (2007) Acetylcholinesterase inhibitors for dementia-an update. MMW Fortschr Med 149: 76-78.
2. Behra M, Cousin X, Bertrand C, Vonesch JL, Biellmann D, Chatonnet A, Strahle U (2002) Acetylcholinesterase is required for neuronal and muscular development in the zebrafish embryo. Nat Neurosci 5: 111-118.
3. Bolognesi ML, Cavalli A, Valgimigli L, Bartolini M, Rosini M, Andrisano V, Recanatini M, Melchiorre C (2007) Multi-target-directed drug design strategy: from a dual binding site acetylcholinesterase inhibitor to a trifunctional compound against Alzheimer's disease. J Med Chem 50: 6446-6449.
4. Bradford MM (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 218-254.
5. Bury N, Grosell M (2003) Iron acquisition by teleost fish. Comp Biochem Physiol C Toxicol Pharmacol 135: 97-105.
6. Chen JC, Hardy PA, Kucharczyk W, Clauberg M, Joshi JG, Vourlas A, Dhar M, Henkelman RM (1993) MR of human postmortem brain tissue: correlative study between T2 and assays of iron and ferritin in Parkinson and Huntington disease. Neuroradiol 14: 275-281.
7. Chen WY, John JA, Lin CH, Lin HF, Wu SC, Lin CH, Chang CY (2004) Expression of metallothionein gene during embryonic and early larval development in zebrafish. Aquat Toxicol 69(3): 215-227.
8. Crichton RR (2001) Inorganic biochemistry of iron metabolism. Wiley, London.
9. Crichton RR, Wilmet S, Legssyer R, Ward RJ (2002) Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells. J Inorg Biochem 91: 9-18.
10. Cuajungco MP, Fagét KY, Huang X, Tanzi RE, Bush AI (2000) Metal chelation as a potential therapy for Alzheimer's disease. Ann N Y Acad Sci 920: 292-304.
11. Dexter DT, Carayon A, Javoy-Agid F, Agid Y, Wells FR, Daniel SE, Lees AJ, Jenner P, Marsden CD (1991) Alterations in the levels of iron, ferritin and other trace metals in Parkinson's disease and other neurodegenerative diseases affecting the basal ganglia. Brain 114: 1953-1975.
12. Dexter DT, Jenner P, Schapira AH, Marsden CD (1992) Alterations in levels of iron, ferritin, and other trace metals in neurodegenerative diseases affecting the basal ganglia. The Royal Kings and Queens Parkinson's Disease Research Group. Ann Neurol 32: 94-100.
13. Donovan A, Brownlie A, Dorschner MO, Zhou Y, Pratt SJ, Paw BH, Phillips RB, Thisse C, Thisse B, Zon LI (2002) The zebrafish mutant gene chardonnay (cdy) encodes divalent metal transporter 1 (DMT1). Blood 100: 4655-4659.
14. Ellman GL, Courtney KD, Andres V Jr, Feather-Stone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7: 88-95.
15. Feder JN, Gnirke A, Thomas W et al (1996) A novel MHC class 1-like gene is mutated in patients with hereditary hemochromatosis. Nat Genet 13: 399-408.
16. Fraenkel PG, Traver D, Donovan A, Zahrieh D, Zon L (2005) Ferroportin 1 is required for normal iron cycling in zebrafish. J Clin Invest 115: 1532-1541.
17. Fredriksson A, Archer T (2003) Effect of postnatal iron administration on MPTP-induced behavioral deficits and neurotoxicity: behavioral enhancement by L-Dopa-MK-801 co-administration. Behav Brain Res 139: 31-46.
18. Fredriksson A, Schröder N, Eriksson N, Izquierdo I, Archer T (1999) Neonatal iron exposure induces neurobehavioural dysfunctions in adult mice. Toxicol Appl Pharmacol 159: 25-30.
19. Fredriksson A, Schröder N, Eriksson N, Izquierdo I, Archer T (2001) Neonatal iron potentiates adult MPTP-induced neurodegenerative and functional deficits. Parkinsonism Relat Disord 7: 97-105.
20. Geiser DL, Zhang D, Winzerling JJ (2006) Secreted ferritin: mosquito defense against iron overload? Insect Biochem Mol Biol 36: 177-187.
21. Gerlai R, Lee V, Blaser R (2006) Effects of acute and chronic ethanol exposure on the behavior of adult Zebrafish (Danio rerio). Pharmacol Biochem Behav 85: 752-761.
22. Goldsmith P (2004) Zebrafish as a pharmacological tool: the how, why and when. Curr Opin Pharmacol 4: 504-512.
23. Guo S (2004) Linking genes to brain, behavior and neurological disease what can we learn from zebrafish. Genes Brain Behav 3: 63-74.
24. Hasselbalch SG, Kampmann JP (2009) Treatment of degenerative dementia disorders-who should be treated? Ugeskr Laeger 171: 802-805.
25. Herlenius E, Lagercrantz H (2004) Development of neurotransmitter systems during critical periods. Exp Neurol 190: 8-21.
26. Hill AJ, Teraoka H, Heideman W, Peterson RE (2005) Zebrafish as a model vertebrate for investigating chemical toxicity. Toxicol Sci 86: 6-19.
27. Kaizer RR, Corrêa MC, Spanevello RM, Morsch VW, Mazzanti CM, Gonçalves JF, Schetinger MR (2005) Acetylcholinesterase activation and enhanced lipid peroxidation after long-term exposure to low levels of aluminum on different mouse brain regions. J Inorg Biochem 99: 1865-1870.
28. Keller M, Robitzki A, Layer PG (2001) Heterologous expression of acetylcholinesterase affects proliferation and glial cytoskeleton of adherent chicken retinal cells. Cell Tissue Res 306(2): 187-198.
29. Lima I, Pedrozo M (2001) Ecotoxicologia do ferro e seus compostos. CRA, Salvador.
30. Lima MN, Laranja DC, Caldana F, Grazziotin MM, Garcia V, Dal-Pizzol F, Bromberg E, Schröder N (2005a) Selengiline protects against recognition memory impairment induced by neonatal iron treatment. Exp Neurol 196: 177-183.
31. Lima MN, Polydoro M, Laranja D, Bonatto F, Bromemberg E, Moreira JC, Dal-Pizzol F, Schröder N (2005b) Recognition memory impairment and brain oxidative stress induced by postnatal iron administration. Eur J Neurosci 21: 2521-2528.
32. Lima MN, Dias C, Torres J, Dornelles A, Garcia V, Scalco F, Guimarães MR, Petry R, Bromberg E, Constantino L, Budni P, Dal-Pizzol F, Schröder N (2007) Reversion of age-related recognition memory impairment by iron chelation in rats. Neurobiol Aging 29: 1052-1059.
33. Lumsden A, Henshall T, Dayan S, Lardelli M, Richards R (2007) Huntingtin deficient zebrafish exhibit defects in iron utilization and development. Hum Mol Genet 16: 1905-1920.
34. Nelson PT, Kryscio RJ, Abner EL, Schmitt FA, Jicha GA, Mendiondo MS, Cooper G, Smith CB, Markesbery WR (2009) Acetylcholinesterase inhibitor treatment is associated with relatively slow cognitive decline in patients with Alzheimer's disease and AD + DLB. J Alzheimers Dis 16: 29-34.
35. Njajou OT, Vaessen N, Joosse M (2001) A mutation in SLC11A3 is associated with autosomal dominant hemochromatosis. Nat Genet 28: 213-214.
36. Oakley AE, Collingwood JF, Dobson J, Love G, Perrott HR, Edwardson JA, Elstner M, Morris CM (2007) Individual dopaminergic neurons show raised iron levels in Parkinson disease. Neurology 68: 1820-1825.
37. Orhan G, Orhan I, Subutay-Oztekin N, Ak F, Sener B (2009) Contemporary anticholinesterase pharmaceuticals of natural origin and their synthetic analogues for the treatment of Alzheimer's disease. Recent Pat CNS Drug Discov 4: 43-51.
38. Park E, Lee Y, Kim Y, Lee C (2008) Cholinergic modulation of neural activity in the telencephalon of the zebrafish. Neurosci Lett 439: 79-83.
39. Rico EP, Rosemberg DB, Senger MR, Arizi MB, Bernardi GF, Bogo MR, Bonan CD (2006) Methanol alters ecto-nucleotidases and acetylcholinesterase in zebrafish brain. Neurotoxicol Teratol 28: 489-496.
40. Rico EP, Rosenberg DB, Dias RD, Bogo MR, Bonan CD (2007) Ethanol alters acetylcholinesterase activity and gene expression in zebrafish brain. Toxicol Lett 174: 25-30.
41. Robitzki A, Mack A, Hoppe U, Chatonnet A, Layer PG (1997) Regulation of cholinesterase gene expression affects neuronal differentiation as revealed by transfection studies on reaggregating embryonic chicken retinal cells. Eur J Neurosci. 9(11): 2394-2405.
42. Roex EW, Keijzers R, van Gestel CA (2003) Acetylcholinesterase inhibition and increased food consumption rate in the zebrafish, Danio rerio, after chronic exposure to parathion. Aquat Toxicol 64: 451-460.
43. Rubinstein AL (2003) Zebrafish from disease modeling to drug discovery. Curr Opin Drug Discov Dev 6: 218-223.
44. Schröder N, Fredriksson A, Vianna M, Roesler R, Izquierdo I, Archer T (2001) Memory deficits in adult rats following postnatal iron administration. Behav Brain Res 124: 77-85.
45. Senger M, Rosemberg DB, Rico EP, Arizzi MB, Dias RD, Bogo MR, Bonan CD (2006) In Vitro Effect of Zinc adn Cadmium on Acetylcholinesterase and Ectonucleotidase Activities in Zebrafish (Danio rerio) Brain. Toxicol In Vitro 20: 954-958.
46. Storr T, Merkel M, Song-Zhao GX, Scott LE, Green DE, Bowen ML, Thompson KH, Patrick BO, Schugar HJ, Orvig C (2007) Synthesis, characterization, and metal coordinating ability of multifunctional carbohydrate-containing compounds for Alzheimer's therapy. J Am Chem Soc 129: 7453-7463.
47. Ward RJ, Kuhn LC, Kaldy P, Florence A, Peters TJ, Crichton RR (1994) Control of cellular iron homeostasis by iron-responsive elements In vivo. Eur J Biochem 220: 927-931.
48. Watanabe T, Yamagata N, Takasaki K, Sano K, Hayakawa K, Katsurabayashi S, Egashira N, Mishima K, Iwasaki K, Fujiwara M (2009) Decreased acetylcholine release is correlated to memory impairment in the Tg2576 transgenic mouse model of Alzheimer's disease. Brain Res 1249: 222-228.
49. Zecca L, Youdim MB, Riederer P, Connor JR, Crichton RR (2004) Iron, brain ageing and neurodegenerative disorders. Nat Rev Neurosci 5: 863-873.